Abstract: The invention provides a corneal path one-way aqueous humor drainage device, in which a Tesla valve unit group drainage channel is formed for draining aqueous humor to the ocular surface, and the drainage channel is a one-way drainage. The aqueous humor diverter provided by the utility model introduces a Tesla valve as a structure to prevent the backflow of aqueous humor. When the liquid flows into the Tesla valve unit group from the liquid outlet, the Tesla valve unit group can block the liquid from entering the liquid. Oral flow. The aqueous humor drainage device can be used for glaucoma patients to reduce intraocular pressure and can also be used for severe dry eye; it is made of materials with good biocompatibility and has high clinical drainage efficiency; its structure.

Abstract: A minimally invasive ab interno triple surgery for open-angle glaucoma comprises knotting and fixing a suture at the head end of an optical fiber catheter; performing miosis with carbachol, injecting the viscoelastic into the anterior chamber, making a lateral incision at the infratemporal corneal limbus, and placing the optical fiber catheter; cutting the Schlemm's canal on the nasal side of the anterior chamber, inserting an optical fiber into the incision on the Schlemm's canal, and cutting off the suture; injecting the viscoelastic to expand while retreating the microcatheter, and regularly injecting the viscoelastic; making a conjunctival flap on the eye and nose side, performing anterior chamber paracentesis, clamping out the suture using intraocular microforceps, and knotting in the sclera tunnel; and suturing the conjunctival flap using the suture, coating the eyes, and covering the eyes with gauze to finish the surgery.

Abstract: Disclosed are a method and a device for generating a refractive pattern, and a computer-readable storage medium. The method includes: capturing fundus images of a human eye to be measured, and obtaining refractive information corresponding to the fundus images; calculating resolutions of the fundus images, and generating a resolution sequence of the fundus images according to the resolutions; confirming target resolutions in the resolution sequence, and obtaining the refractive information of fundus images corresponding to the target resolutions; and generating a refractive matrix according to the refractive information, and generating the refractive pattern according to the refractive matrix.

Abstract: The present invention belongs to the field of medicine and relates to a pharmaceutical composition for preventing and treating NITM and a medical use thereof. Specifically, the pharmaceutical composition is an ophthalmic pharmaceutical composition such as an ophthalmic preparation. Specifically, the present invention relates to a pharmaceutical composition comprising 0.001% to 0.2% of atropine or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients; wherein the pH value of the pharmaceutical composition is of 4.0 to 6.5; the pharmaceutical composition comprises 0.5% to 5% of a pH adjusting agent, and the pH adjusting agent is any one or more selected from sodium dihydrogen phosphate, disodium hydrogen phosphate, citric acid, citrate, boric acid and borates. The pharmaceutical composition of the present invention can effectively treat and/or prevent NITM, and thus has a good application prospect.

Abstract: An active peptide for enhancing the phagocytic functions of retinal pigment epithelium and a use thereof, which belongs to the technical field of preparing drugs for treating retinal neurodegenerative diseases, are described. The amino acid sequence of the active peptide for enhancing the phagocytic functions of retinal pigment epithelium described in the disclosure was as shown in SEQ ID NO.1. The active peptide of the present invention has biological characteristics similar to those of Gas6 full-length proteins, with an effect of enhancing the phagocytic functions of retinal pigment epithelium.

Abstract: The disclosure relates to an active peptide for enhancing the phagocytic functions of retinal pigment epithelium and a use thereof, which belongs to the technical field of preparing drugs for treating retinal neurodegenerative diseases. The amino acid sequence of the active peptide for enhancing the phagocytic functions of retinal pigment epithelium described in the disclosure was as shown in SEQ ID NO.1. The active peptide of the present invention has biological characteristics similar to those of Gash full-length proteins, with an effect of enhancing the phagocytic functions of retinal pigment epithelium.

Abstract: Retina digital imaging system, instrument and method A retina digital imaging system includes: an illumination module (1), a main optical assembly (3), and an image sensor module (2); the illumination module (1) includes light-emitting diodes capable of emitting light with different wavelengths, and each light-emitting diode emits light to enter the retina through the main optical assembly (3) to form an illumination optical path; the light reflected by the retina passes through the main optical assembly (3) and forms an image on the image sensor module (2) to form an imaging optical path. The various spectral bands formed by light-emitting diodes may form a wider spectrum, so different layers of the retina may be imaged to provide valuable medical and diagnostic data.